GENEVA, Dec. 31 -- LEAPFROG BIO, INC. (400 Oyster Point Blvd, Suite 203South San Francisco, California 94080) filed a patent application (PCT/US2025/033829) for "P110 INHIBITORS FOR THE TREATMENT OF CANCER" on Jun 16, 2025. With publication no. WO/2025/264581, the details related to the patent application was published on Dec 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): BABAK, Tomas (400 Oyster Point Blvd, Suite 203South San Francisco, California 94080), HEINECKE, Peter (400 Oyster Point Blvd, Suite 203San Mateo, California 94080)
Abstract: Provided herein, in some embodiments, are m...